What will work for individual patients involves trial and error during the treatment process. Now, a team of researchers led ...

Researchers found that adolescents treated with a glucagon-like peptide 1 receptor agonist (GLP1R) for obesity experienced ...

About Biora Therapeutics Biora Therapeutics is a clinical-stage biotech company developing two smart pill-based therapeutics platforms: the NaviCapTM platform for colon-targeted treatment of IBD , ...

Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients ...

In a study that identified male chromosome genetic material in the intestines of female patients undergoing fecal transplants, researchers say they have significantly expanded scientific understanding ...

Detection rate of cancer-causing growths can be up to 15 per cent higher through this method, says colorectal surgeon Pauleon ...

Marquis Who's Who has honored Francis S. Kim for expertise in the health care field. Dr. Kim currently serves as the medical ...

Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients involves trial and error ...

Hepatitis E Virus, or HEV, is a viral infection that generates inflammation of the liver. The disease is commonly transmitted through contact with contamin | Immunology ...

Ro explores the relationship between fiber and weight loss, six high-fiber foods for weight loss, and how incorporating these ...

For the third quarter of 2024, the Company reported a net loss attributable to common stockholders of $4.9 million, or $5.79 per share, compared to $7.9 million, or $14.20 per share in the third ...

SAN CARLOS, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antibodies for the treatment of allergic, inflammatory and ...